Background and Objectives: HIV patients have seen accelerated ageing. Our objective was to determine the prevalence of frailty, to evaluate factors associated with frailty and to evaluate physical function in older HIV-infected adults. Design: this was a cross-sectional study. Setting: outpatient clinics of two public university hospitals in Madrid (Spain). Methods: frailty was defined according to the criteria of Fried: shrinking, weakness, poor endurance and energy, slowness and low physical activity level, being frail those who met at least three criteria, prefrail one or two criteria and robust when they met no criteria. Physical function was assessed using standardised methods. Results: we evaluated 117 HIV-infected patients. Mean age was 61.3 ([standard deviation] 6.87) years. All patients were on antiretroviral therapy. Median current CD4+ T-cell count was 638 (144-1871) cells/μl, and median CD4/CD8 ratio was 0.79 (0.00-3.62). The prevalence of frailty was 15.4%, and that of prefrailty was 52.1%. In the multivariate analyses depressive symptoms (OR [95% CI], 9.20 [2.17-39.05]) and CD4/CD8 ratio (OR 0.11 [0.02-0.61]) were associated with frailty. Even though 100% of the patients were able to walk and perform basic activities of daily life independently, functional impairment was high (20% slow gait and 55% Short Physical Performance Battery ≤9). Conclusions: HIV-infected patients aged ≥55 years have a high prevalence of frailty and a high burden of functional impairment. Optimal management of this population requires close collaboration between infectious diseases specialists and geriatricians.
Introduction
The HIV-infected population is ageing [1, 2] . The heterogeneity of older HIV-infected adults highlights the relevance of identifying those who are at risk of unhealthy ageing. Frailty is a syndrome that identifies persons at risk of adverse health events who are more vulnerable to stressors than others [3] [4] [5] [6] [7] [8] [9] [10] [11] . An association between HIV infection and early development of frailty has been suggested [12] . Scientific evidence regarding this topic has been increased in the last years, but most information comes from epidemiological studies designed for other purposes based on adapted criteria for frailty that have been limited to specific risk groups [12] [13] [14] [15] [16] [17] . Furthermore, since HIV patients have seen accelerated ageing [18] , it is likely that many people ageing with treated HIV infection may have their physical function affected [19] . The main objective of our study was to assess the prevalence of frailty according to the criteria of Fried and to evaluate physical function in a cohort of older HIV-infected adults.
Methods

Study design and patient population
We performed a cross-sectional study in two university hospitals in Madrid (Spain). The inclusion criteria were confirmed HIV infection, age ≥55 years at the time of recruitment and regular follow-up at the HIV clinics. Consecutive patients attending the clinics were included between June 2014 and June 2015. The Ethics Committee of each hospital approved the study. The objectives were to know the prevalence of frailty, analyse factors associated with frailty and evaluate physical function in our cohort.
Data collection
We recorded sociodemographic data, comorbidities (selfreported physician-diagnosed chronic conditions but also the Cumulative Illness Rating Scale for Geriatrics [CIRS-G]) [20] , medications (polypharmacy was defined as taking ≥6 medications) and variables related to HIV infection (risk practice for HIV infection, the baseline and current immunovirologic status, and the stage of HIV infection at diagnosis) [21] . Cognitive status was evaluated using the Mini-Mental State Examination (MMSE) [22] , the Clock Drawing Test [23] and the Short Geriatric Depression Scale (S-GDS or Yesavage Test) for testing depression [24] . The recorded laboratory data included HIV-related data (HIV-RNA, CD4 count, CD4/CD8 ratio), HCV and/ or HBV coinfection, nutritional profile (proteins, albumin, cholesterol) and vitamin D levels.
Frailty
Frailty was defined according to the criteria of Fried et al. [3] , namely, shrinking (unintentional weight loss of ≥4.5 kg or ≥5% of body weight during the previous year), weakness (grip strength adjusted for gender and body mass index), poor endurance and energy (self-reported exhaustion identified by two questions from the Center for Epidemiologic Studies Depression scale), slowness (based on time to walk 15 feet, adjusting for gender and standing height) and low physical activity level (<383 kcal/week in men and <270 kcal/week in women using the Minnesota Leisure Time Activity Questionnaire). Patients were considered frail when they met at least three of the five criteria, prefrail when they met one or two criteria and robust when they met no criteria.
Physical function
Physical function was assessed by quantifying the patient's independence for walking and performing activities of daily living (ADLs) using the functional ambulation classification (FAC) [25] , the Barthel index (BI) [26] and the Short-Form Late-Life Function and Disability Instrument (SF-LLFDI) [27] but also with objective measures of strength, gait speed and balance using the Short Physical Performance Battery (SPPB) [28] .
Statistical analysis
We used descriptive statistics to examine participant characteristics, which are expressed as frequency (percent) for categorical variables, mean (standard deviation [SD]) for normally distributed continuous variables, and median (interquartile range) for continuous variables with a skewed distribution. Continuous variables were compared using the t-test for independent variables. The Mann-Whitney test was used for variables with a non-normal distribution or when the group size was small. The association between qualitative variables was assessed using the chi-square test or the Fisher exact test when the groups were very small. Multivariate logistic regression analyses were performed for those variables found to be associated with frailty in the univariate analyses in order to determine, which were independently associated with frailty. Frailty was treated as a binary variable so a combined group of prefrail and robust served as the control.
Results
We evaluated 117 HIV-infected patients aged ≥55 years. Baseline characteristics are presented in Supplementary data, Appendix 2, available in Age and Ageing online. All patients were on antiretroviral therapy and were immunovirologically well controlled. The HIV-RNA was detectable in only one patient with poor adherence to treatment. She was not frail. Comorbidities are detailed in Supplementary data, Appendix 2, available in Age and Ageing online. According to the CIRS-G, the mean total score was 6.07 with a mean severity index of 1.62. The mean number of medications used was 5.52 per patient, with half of the patients receiving ≥6 medications.
According to the criteria of Fried, the prevalence of frailty was 15.4% and 52.1% of patients were prefrail. In the univariate analysis, frailty was found to be associated with the CD4/CD8 ratio (P = 0.03), an MMSE score of 19-23 (P = 0.05), a S-GDS score of >6 points (i.e. depressive symptoms) (P = 0.002), chronic liver disease (P = 0.03) and albumin (P = 0.004). No association was found between frailty and gender, education, risk practices for HIV infection, age at HIV diagnosis, duration of HIV infection, CD4 T-cell nadir, current CD4 T-cell count, maximum plasma HIV-RNA, CDC Stage B or C, monotherapy or dual therapy in the 1980s-90s, social situation, alcohol consumption, treatment with benzodiazepines, polypharmacy, the presence of specific comorbidities, severity according to CIRS-G and vitamin D levels. The multivariate analysis revealed that only an S-GDS score of >6 points (OR [95% CI], 9.20 [2. .05]) and a high CD4/CD8 ratio (OR [95% CI], 0.11 [0.02-0.61]) were found to be independently associated with the risk of frailty (Table 1) The results of the Physical Function Assessment are shown in Table 2 . All the patients were able to walk independently and to perform basic ADLs independently. About 20.5% of the patients had a slow gait (speed <0.8 m/s), and more than half of the patients (55.5%) had an SPPB score of ≤9, which means some grade of functional impairment and risk of disability.
Discussion
This comprehensive study was performed to measure the prevalence of frailty and to assess physical function in older HIV-infected adults. The prevalence of frailty we found (15.4%) was twice as high as that of the original Fried study on frailty performed in men and women aged ≥65 years (7%) [3] , and that of the most representative Spanish frailty cohort in the general population (7.1% in communitydwelling persons aged ≥70 years) [11] . The most representative study on frailty recently published found an overall prevalence of frailty of 15.3% but it was diminished for persons not receiving help in any self-care task (9.6%) [29] . Therefore, we can state that the prevalence of frailty as defined by the criteria of Fried et al. was higher in our cohort of HIV-infected patients aged ≥55 years than previously found in the non-infected population of at least 10 years older. We found that depressive symptoms were associated with a 9.2-fold increase in the risk of frailty. This association was shown in a previous study, with a 3.17-fold increase in the risk of frailty among HIV-infected patients [30] . We found the CD4/CD8 ratio to be independently associated with the risk of frailty (OR 0.11 [0.02-0.61]), as described in a previous study in HIV-infected women [31] . The CD4/CD8 ratio has been similarly used as a biomarker in HIV infection as was previously described in non-HIV older people [32] . A low CD4/CD8 ratio has been linked to a poor prognosis in HIV-infected patients [33] [34] [35] . The CD4/CD8 ratio has been proposed to identity patients at risk of non-AIDS-related events [36] and we suggest it was also to identify frail HIV patients who might need more attention
In our study, a huge physical function assessment in older HIV-infected patients was made. Measurements of functional limitations have the advantage of being more sensitive to higher functioning individuals compared to disability measurements, and because of that we focused on objective measurements like SPPB and gait speed. In our study, one in five older HIV-infected patients had a slow gait (<0.8 m/s) and more than half had an SPPB score of <9, so functional impairment was found to be prevalent. An independent association between HIV infection and reduced physical performance has been demonstrated previously [37, 38] , although in a lower proportion of patients than that found in our study, even though our population is 10 years older (mean age 51 years [37] , mean age 50.8 years [38] ). Our study is subject to a series of limitations. Some analyses may have been restricted by the sample size. We did not compare with a control group of non-HIV-infected subjects; however, we compared our results with those of the three largest studies that used the frailty criteria of Fried et al. [3] (not an adapted phenotype) in community-dwelling older adults, all of which found a very similar prevalence despite the fact that two were performed in the USA [3] and the other in Spain [11] . One of the strengths of our study is that it did not focus on any specific group of HIV-infected patients; therefore, our findings could reasonably be extrapolated to the general HIV-infected population and the other strength is the extensive physical function assessment that was made, which was not made before.
In summary, our results demonstrate a high prevalence of frailty and functional impairment among HIV-infected patients aged ≥55 years. The routine assessment of frailty and physical performance in older HIV-infected patients may help to identify persons with a preclinical stage of disability who can take advantage of early interventions to restore their functional status. The assessment of these patients requires a specific approach with close collaboration between infectious diseases specialists and geriatricians.
Key points
• We found a high prevalence of frailty (15.2%) in the older HIV-infected population. Depressive symptoms were associated with a 9.2-fold increase in the risk of frailty in the older HIV-infected patients. • The CD4/CD8 ratio was significantly inversely associated with the risk of frailty in the older HIV-infected patients.
• A specific approach of older HIV-infected patients is required with HIV specialists and geriatricians working together.
• Functional impairment was found to be prevalent in the older HIV-infected patients.
Supplementary data
Supplementary data are available at Age and Ageing online.
Conflict of interest
None declared.
Ethics committee approval
The Ethics Committee of both participant hospital approved the study.
